Detalhe da pesquisa
1.
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.
Breast Cancer Res Treat;
201(3): 377-385, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37344660
2.
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing.
Br J Cancer;
127(7): 1304-1311, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35842545
3.
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders.
J Formos Med Assoc;
121(12): 2538-2547, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35752529
4.
Genetic alterations and their therapeutic implications in epithelial ovarian cancer.
BMC Cancer;
21(1): 499, 2021 May 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33947352
5.
Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor.
Mod Pathol;
33(12): 2534-2543, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32616873
6.
Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
Gynecol Oncol;
155(2): 275-279, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31481248
7.
Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma.
Clin Transl Immunology;
12(8): e1465, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37649975
8.
Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer.
Biomed J;
46(5): 100563, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36208860
9.
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
Hepatol Int;
16(5): 1137-1149, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35780451
10.
Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1.
Cancers (Basel);
14(7)2022 Mar 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35406559
11.
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.
Clin Cancer Res;
28(19): 4248-4257, 2022 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35849151
12.
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.
Target Oncol;
17(3): 355-368, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35699834
13.
Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations.
J Pers Med;
11(5)2021 Apr 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33946955
14.
Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.
Curr Oncol;
28(6): 4587-4596, 2021 11 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34898561
15.
Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Onco Targets Ther;
14: 3895-3901, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34234458
16.
Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.
Clin Transl Med;
11(12): e674, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34954904
17.
Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
J Mol Med (Berl);
99(7): 959-966, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33768299
18.
Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab.
Case Rep Oncol Med;
2020: 9072173, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32190395
19.
A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis.
Sci Rep;
10(1): 13604, 2020 08 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32788598
20.
Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse.
Expert Rev Mol Diagn;
20(11): 1149-1159, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33040630